Comparison of the efficacy and safety of sertraline, reboxetine, and venlafaxine in patients with major depressive disorder: a pooled analysis of four randomized, open-label trials
Cengiz Akkaya, Selcuk Kırlı, Salih Saygin, Sengul Cangur, Mustafa Canbazoglu, Asli Sarandol
( Psychiatry and Clinical Psychopharmacology 2010; 20: 274-287)